Literature DB >> 25762821

Iatrogenic thyrotoxicosis secondary to compounded liothyronine.

Ajay Bains1, Ami-Joseph Brosseau2, David Harrison3.   

Abstract

Entities:  

Year:  2015        PMID： 25762821      PMCID： PMC4350501          DOI： 10.4212/cjhp.v68i1.1426

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  3 in total

1.  Custom-compounded micronized hormones in a slow-release capsule matrix.

Authors:  Evelyn D Timmons; Steven P Timmons
Journal:  Int J Pharm Compd       Date:  2002

Review 2.  The use of hypromellose in oral drug delivery.

Authors:  Chi L Li; Luigi G Martini; James L Ford; Matthew Roberts
Journal:  J Pharm Pharmacol       Date:  2005-05       Impact factor: 3.765

Review 3.  Comparative pharmacology of the thyroid hormones.

Authors:  E Sypniewski
Journal:  Ann Thorac Surg       Date:  1993-07       Impact factor: 4.330
  3 in total
  3 in total

Review 1.  Thyroid hormone misuse and abuse.

Authors:  Victor J Bernet
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

2.  Severe TSH Elevation and Pituitary Enlargement After Changing Thyroid Replacement to Compounded T4/T3 Therapy.

Authors:  Adlai L Pappy; Nelson Oyesiku; Adriana Ioachimescu
Journal:  J Investig Med High Impact Case Rep       Date:  2016-08-02

Review 3.  Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance.

Authors:  Colin Dayan; Vijay Panicker
Journal:  Thyroid Res       Date:  2018-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.